Question explored with the scientific record
Conversation so far
- …started from a private conversation
- 1 unclear. does a drop in blood pressure due to medication signall any danger if standing or moving there is no dizziness or faitness.
- 2 How do I know if this BP drop is orthostatic hypotension?
Answered on this page ↓
How do I know if this BP drop is orthostatic hypotension?
The short version: you can tell by measuring your blood pressure lying down, then standing, and checking the numbers against a standard threshold.
The standard definition is a drop in systolic BP of at least 20 mmHg or diastolic BP of at least 10 mmHg within 3 minutes of standing [15]. You need a cuff and a timer. Take your BP after 5 minutes lying flat, then stand and take it again at 1 minute and at 3 minutes. If the numbers fall past those thresholds, you have orthostatic hypotension by definition, whether you feel dizzy or not.
The evidence shows that medication-related drops are common and often silent. In one study of elderly patients, 86% of those who met the definition had no symptoms at all [9]. So the absence of dizziness does not rule it out. The measurement is what settles it, not how you feel.
My call: take the lying and standing BP readings yourself with a home cuff. If the systolic drops 20 or more, or the diastolic drops 10 or more, that is orthostatic hypotension regardless of symptoms. Confidence: high.
Sources used 21
-
Effects of Bromocriptine on Plasma Catecholamines in Normal Men
Bromocriptine acutely lowers plasma catecholamines (DA, NE, E) in normal men, with rapid, significant suppression that is transient after a week of dosing but reproducible with a second dose; standing-induced CA responses persist; basal gonadal hormones are unaffected.
DOI: 10.1159/000122891 -
Orthostatic hypotension before and after meal intake in diabetic patients and healthy elderly people
Postural and postprandial cardiovascular responses (heart rate and blood pressure) were compared between diabetic patients and healthy elderly individuals, showing aging-related standing SBP drops and higher resting HR, while diabetes did not significantly alter orthostatic hypo…
DOI: 10.4103/2230-8229.94007 -
L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension
This study investigates the efficacy of droxidopa, a synthetic amino acid, in treating neurogenic orthostatic hypotension by increasing standing blood pressure and improving symptoms in patients with degenerative autonomic disorders.
DOI: 10.1007/s10286-007-1002-2 -
Management of initial orthostatic hypotension: lower body muscle tensing attenuates the transient arterial blood pressure decrease upon standing from squatting
This study investigates the effectiveness of lower body muscle tensing (LBMT) in attenuating initial orthostatic hypotension (IOH) symptoms in patients and healthy subjects after standing from a squatting position, finding that LBMT significantly increases mean arterial pressure…
DOI: 10.1042/CS20070064 -
Impairment of cerebral autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic hypotension
This study investigates the impairment of cerebral autoregulation in diabetic patients with cardiovascular autonomic neuropathy and orthostatic hypotension, revealing significant instability in cerebral blood flow upon standing.
DOI: 10.1046/j.1464-5491.2003.00885.x -
Initial orthostatic hypotension is unrelated to orthostatic tolerance in healthy young subjects
This study investigates the relationship between initial orthostatic hypotension (IOH) and syncope in healthy young individuals, finding that while both conditions exhibit similar physiological changes, they are distinct phenomena with no direct correlation between the severity …
DOI: 10.1152/japplphysiol.91650.2008 -
Safety and Durability of Effect with Long-Term, Open-Label Droxidopa Treatment in Patients with Symptomatic Neurogenic Orthostatic Hypotension (NOH303)
A multinational, 12-month open-label extension study shows that long-term droxidopa treatment for symptomatic neurogenic orthostatic hypotension is generally safe and provides durable improvements in symptoms and standing blood pressure, with no significant difference versus pla…
DOI: 10.3233/JPD-160860 -
Coenzyme Q10 Supplementation in Orthostatic Hypotension and Multiple-System Atrophy: A Report on 7 Cases
Coenzyme Q10 supplementation in seven elderly patients with orthostatic hypotension (some with suspected MSA) reduced the standing blood pressure drop and was subjectively beneficial, suggesting potential for randomized trials.
DOI: 10.1016/j.amjmed.2017.10.021 -
Effects of compression stockings on blood pressure and its orthostatic change in female subjects
This study investigates the effects of compression stockings on blood pressure and heart rate in non-hypertensive female subjects, finding that they significantly elevate supine systolic blood pressure in hypotensive individuals and reduce orthostatic changes during active stand…
DOI: 10.1016/s0928-4680(97)00161-2 -
Forearm Blood Flow Response to Posture Change in the Very Old: Non‐Invasive Measurement by Venous Occlusion Plethysmography
In a cohort comparing healthy young, healthy old, and impaired elderly, mean forearm vascular resistance increase at 1 minute of standing was significantly smaller in elderly groups than young, but by 3 minutes similar; five impaired elderly developed orthostatic hypotension.
DOI: 10.1111/j.1532-5415.1991.tb05906.x -
Droxidopa for neurogenic orthostatic hypotension
A large phase 3 randomized trial shows that droxidopa, after open-label dose optimization, significantly improves patient-reported symptoms and standing blood pressure in patients with symptomatic neurogenic orthostatic hypotension across etiologies, with good short-term tolerab…
DOI: 10.1212/wnl.0000000000000615 -
Relationship between orthostatic hypotension and cognitive impairment in the elderly
This study investigates the relationship between orthostatic hypotension and cognitive impairment in elderly patients, finding that those with orthostatic hypotension exhibit worse cognitive function compared to those without it.
DOI: 10.1016/j.jns.2010.08.056 -
Why and How We Should Treat Elderly Patients with Hypertension?
A comprehensive review of evidence showing antihypertensive therapy reduces cardiovascular events in the elderly, outlining current BP targets (generally <140/90 mm Hg and <130/80 mm Hg for diabetes or CKD), discussing practical treatment approaches and risks such as orthostatic…
DOI: 10.2174/157016110793563933 -
The Antihypertensive Effects of a Pure and Selective Serotonin-Receptor Blocking Agent (R 41 468) in Elderly Patients
The study shows that a pure serotonin-5-HT2 receptor blocking agent, R 41 468, lowers blood pressure in elderly hypertensive patients when given intravenously and as an 8-day oral course, with sustained reductions during maintenance therapy and minimal cardiovascular side effect…
DOI: 10.1177/000331978103200206 -
Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications
This narrative review surveys medications that predispose to drug-related orthostatic hypotension, detailing the mechanisms and relative risks across drug classes, and providing practical strategies for medication review and treatment (including nonpharmacological measures and p…
DOI: 10.1007/s40266-020-00796-5 -
Synthesis and antihypertensive activity of a series of 8-substituted 1-oxa-3,8-diazaspiro[4.5]decan-2-ones
This study investigates the synthesis and antihypertensive activity of a series of 8-substituted 1-oxa-3,8-diazaspiro[4.5]decan-2-ones, revealing their potential as mixed alpha and beta-adrenergic receptor blockers in spontaneously hypertensive rats.
DOI: 10.1021/jm00143a012 -
Management of hypertension in specific populations: a review
This narrative review synthesizes current understanding of hypertension management in four high-risk populations—self-identified Blacks (notably NHB), older adults, chronic kidney disease patients, and kidney transplant recipients—highlighting prevalence, disparities, guideline …
DOI: 10.21037/atm-25-65 -
Impact of hypocapnia and cerebral perfusion on orthostatic tolerance
This study investigates the effects of hypocapnia and cerebral perfusion on orthostatic tolerance, revealing that cerebral hypoperfusion does not significantly impact tolerance time due to compensatory increases in oxygen extraction.
DOI: 10.1113/jphysiol.2014.280586 -
Cognitive Function in Peripheral Autonomic Disorders
This study evaluates cognitive function in patients with peripheral autonomic failure and investigates the impact of orthostatic hypotension on cognitive performance, revealing that while cognitive function is preserved in a seated position, executive functions significantly wor…
DOI: 10.1371/journal.pone.0085020 -
Cerebral autoregulation in orthostatic hypotension. A transcranial Doppler study.
This study used transcranial Doppler to compare cerebral autoregulation during acute hypotension in healthy men and men with autonomic dysfunction, showing intact autoregulation in controls and passive cerebral hemodynamics in patients.
DOI: 10.1161/01.STR.25.9.1771 -
Orthostatic hypotension in older persons is not associated with cognitive functioning, features of cerebral damage or cerebral blood flow
This study investigates the association between orthostatic hypotension and cognitive functioning in older adults, finding no significant relationship between the two, nor with cerebral vascular damage or cerebral blood flow.
DOI: 10.1097/hjh.0000000000001681